Fgh Biotech, Inc.

Calculating rank

USPTO Granted Patents = 4

% Expired Patents = 25.0

CIPO Patents = 1

EPO Patents = 2

Trademarks = 2

Forward Citations = 2

Loading Chart...

4 inventors (with patents filed for the assignee):

Motonari Uesugi (3 out of 13 patents)

Joel Huff (3 out of 3 patents)

John Kincaid (2 out of 19 patents)

4. William R Cantrell, Jr (1 out of 11 patents)

5. Motonari Uesugi (0 patent)

4 patents: Sort by Forward Citations

1. 11497738 - Di-substituted pyrazole compounds for the treatment of diseases (2022-11-15),

2. 11339142 - Di-substituted pyrazole compounds for the treatment of diseases (2022-05-24),

3. 10328064 - Compositions of fatostatin based heterocyclic compounds and uses thereof (2019-06-25),

4. 9873689 - Synthesis of fatostatin based polycyclic compounds (2018-01-23),

Company Overview

Fgh Biotech, Inc. is a leading biotechnology company specializing in the development and production of innovative biopharmaceuticals. With a focus on research, development, and commercialization of advanced therapies, Fgh Biotech is dedicated to improving patient outcomes and advancing the field of biotechnology. The company's state-of-the-art facilities and team of talented scientists ensure high-quality products that meet the needs of healthcare providers and patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

4 Patents

#1,004 in Houston, TX

#3,944 in Texas

#60,704 in US

Houston, TX, United States of America

Fgh Biotech, Inc.

Forward Citations = 2

4 inventors:

Motonari Uesugi (3 out of 13 patents)

Joel Huff (3 out of 3 patents)

John Kincaid (2 out of 19 patents)

4. William R Cantrell, Jr (1 out of 11 patents)

5. Motonari Uesugi (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fgh Biotech, Inc.. Retrieved from https://idiyas.com/company/fgh-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]